Good news concerning Alzheimer’s. An insulin nasal spray may help people with mild memory issues manage their Alzheimer’s disease, according to the findings of a new, small but convincing trial headed by researchers from the Department of Veterans Affairs.
Nonetheless, the authors of the study acknowledge that much more investigation is needed before medical professionals can claim with certainty that such a saline nasal spray product would be beneficial to patients. Though insulin’s effect on glucose uptake is certainly a factor, we also know that insulin in the brain functions differently than it does in the rest of the body, so there may be more to the connection than meets the eye.
Unfortunately, we also know that there is presently no way to halt the progression of Alzheimer’s disease or other forms of dementia.
The disorders of obesity and type 2 diabetes have been linked to an increased risk of developing Alzheimer’s disease in the past. New evidence suggests a relationship between insulin issues in the brain and cognitive decline.
Study participants included 104 persons with minor memory loss due to Alzheimer’s disease or another cognitive disability named (aMCI).
Patients with Alzheimer’s disease who were given either of the two doses of insulin showed otrivine alternative performance than those who were given the placebo. Overall, those who took a placebo saw slight drops.
Moreover, there is this. When comparing the results of a dementia test http://www.sinusoothe.com given to patients before and after the research was over, those given insulin showed no decrease compared to those given a placebo. Difficulty thinking, memory loss, and language issues are all symptoms of Alzheimer’s disease in its early stages. Problems with insulin are suspected to contribute to certain signs and symptoms. Even though aging is a major risk factor for Alzheimer’s, it is not an age-related condition.
SinuSoothe Ltd 